Last reviewed · How we verify

Saline spray (0.65%) — Competitive Intelligence Brief

Saline spray (0.65%) (Saline spray (0.65%)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Otolaryngology / Nasal Care.

marketed Otolaryngology / Nasal Care Small molecule Live · refreshed every 30 min

Target snapshot

Saline spray (0.65%) (Saline spray (0.65%)) — Washington University School of Medicine. Saline spray delivers a 0.65% sodium chloride solution to nasal passages to cleanse, moisturize, and relieve nasal congestion.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Saline spray (0.65%) TARGET Saline spray (0.65%) Washington University School of Medicine marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Saline spray (0.65%) — Competitive Intelligence Brief. https://druglandscape.com/ci/saline-spray-0-65. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: